SOA Wealth Advisors’s Akero Therapeutics AKRO Stock Holding History

SOA Wealth Advisors’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-102	Closed	-$4.84K	–	870
2025 Q3	$4.84K	Hold	102	–	–	﹤0.01%	669
2025 Q2	$5.44K	Hold	102	–	–	﹤0.01%	649
2025 Q1	$4.13K	Hold	102	–	–	﹤0.01%	648
2024 Q4	$2.84K	Hold	102	–	–	﹤0.01%	659
2024 Q3	$2.93K	Sell	102 -101	-50%	-$2.63K	﹤0.01%	645
2024 Q2	$4.76K	Hold	203	–	–	﹤0.01%	609
2024 Q1	$5.13K	Hold	203	–	–	﹤0.01%	609
2023 Q4	$4.74K	Hold	203	–	–	﹤0.01%	604
2023 Q3	$10.3K	Hold	203	–	–	﹤0.01%	520
2023 Q2	$9.48K	Hold	203	–	–	﹤0.01%	538
2023 Q1	$7.77K	Hold	203	–	–	﹤0.01%	561
2022 Q4	$11.1K	Hold	203	–	–	﹤0.01%	507
2022 Q3	$6K	Hold	203	–	–	﹤0.01%	571
2022 Q2	$1K	Hold	203	–	–	﹤0.01%	729
2022 Q1	$2K	Hold	203	–	–	﹤0.01%	782
2021 Q4	$4K	Buy	+203	New	+$4.5K	﹤0.01%	681

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SOA Wealth Advisors's AKRO Position: Q4 2025 in Review

SOA Wealth Advisors sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 102 shares — an estimated $4.84K sold.

SOA Wealth Advisors first reported a position in AKRO in Q4 2021 and held it in 16 quarters. The position peaked at $11.1K in Q4 2022. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

SOA Wealth Advisors reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
SOA Wealth Advisors sold 102 Akero Therapeutics shares in Q4 2025, an estimated $4.84K.
SOA Wealth Advisors first reported a position in Akero Therapeutics in Q4 2021 and held it in 16 quarters.
SOA Wealth Advisors's Akero Therapeutics position peaked at $11.1K in Q4 2022.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on SOA Wealth Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.